Sex differences in mechanisms of cardiac excitation–contraction coupling

Abstract

The incidence and expression of cardiovascular diseases differs between the sexes. This is not surprising, as cardiac physiology differs between men and women. Clinical and basic science investigations have shown important sex differences in cardiac structure and function. The pervasiveness of sex differences suggests that such differences must be fundamental, likely operating at a cellular level. Indeed, studies have shown that isolated ventricular myocytes from female animals have smaller and slower contractions and underlying calcium transients compared to males. Recent evidence suggests that this arises from sex differences in components of the cardiac excitation–contraction coupling pathway, the sequence of events linking myocyte depolarization to calcium release from the sarcoplasmic reticulum and subsequent contraction. The concept that sex hormones may regulate intracellular calcium at the level of the cardiomyocyte is important, as levels of these hormones decline in both men and women as the incidence of cardiovascular disease rises. This review focuses on the impact of sex on cardiac contraction, in particular at the cellular level, and highlights specific components of the excitation–contraction coupling pathway that differ between the sexes. Understanding sex hormone regulation of calcium homeostasis in the heart may reveal new avenues for therapeutic strategies to treat cardiac dysfunction and cardiovascular diseases.

Age-associated abnormalities of intrinsic automaticity of sinoatrial nodal cells are linked to deficient cAMP-PKA-Ca2+signaling

“…Furthermore, aged-associated changes may occur in different species or in different strains within species. Consequently, the effect of aging cannot be generalized, and it is important to strictly qualify results in aging studies with species, strain (23), sex (11,42), and the specific age range examined (29). In the present study, we compared changes in heart rate mechanisms in adult (2-4 mo) and aged (20 -27 mo) C57 black mice.…”

Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome

“…Previous in vitro and in vivo studies have suggested that high testosterone levels may have pro-arrhythmic effects through modulation of cardiac contraction and calcium homeostasis. [28][29][30][31] Other studies suggested that arrhythmias may occur due to higher adrenergic activity increasing apoptosis, which would worsen ARVC/D pathologies. 32,33 the arrhythmic potential in this specific disease constellation, since in our in vitro model, the healthy CMs did not show increased lipogenesis and apoptosis after 5F pathogenic induction.…”

Sex differences in health and disease: brain and heart connections—a special issue

“…Despite the hypothesized significant role in myocardial function, how these steroid sex hormones perform the tasks responsible for the different outcomes are not yet well understood. Thus, several reviews in this issue have covered the context of sex differences in electrical signal and electrocardiography [22], in mechanical induction by excitation-contraction coupling [19], and in the energetics and metabolism of the heart [26]. Sex differences in cardiac adaptations to differential stresses either physiological, like conditions of exercise-induced cardiac hypertrophy [12] and nonischemic myocardial remodeling [15], or pathological, like ischemia-reperfusion injury [17], have also been included.…”